Precigen, Inc. (PGEN)
6.84
+0.16
(+2.40%)
USD |
NASDAQ |
Sep 11, 16:00
6.84
0.00 (0.00%)
After-Hours: 16:28
Precigen Gross Profit (TTM) : 76.45M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.45M |
| March 31, 2026 | 24.04M |
| December 31, 2025 | 3.588M |
| September 30, 2025 | 0.64M |
| June 30, 2025 | -1.303M |
| March 31, 2025 | -2.254M |
| December 31, 2024 | -2.986M |
| September 30, 2024 | -4.028M |
| June 30, 2024 | -4.638M |
| March 31, 2024 | -3.910M |
| December 31, 2023 | -3.630M |
| September 30, 2023 | -2.946M |
| June 30, 2023 | 12.03M |
| March 31, 2023 | 11.30M |
| December 31, 2022 | 14.69M |
| September 30, 2022 | 16.16M |
| June 30, 2022 | 2.736M |
| March 31, 2022 | 3.923M |
| December 31, 2021 | 12.60M |
| September 30, 2021 | 17.32M |
| June 30, 2021 | 27.15M |
| March 31, 2021 | 42.99M |
| December 31, 2020 | 47.66M |
| September 30, 2020 | 43.71M |
| June 30, 2020 | 37.16M |
| Date | Value |
|---|---|
| March 31, 2020 | 37.76M |
| December 31, 2019 | 29.32M |
| September 30, 2019 | 54.93M |
| June 30, 2019 | 68.21M |
| March 31, 2019 | 78.83M |
| December 31, 2018 | 99.59M |
| September 30, 2018 | 134.06M |
| June 30, 2018 | 147.94M |
| March 31, 2018 | 158.79M |
| December 31, 2017 | 168.19M |
| September 30, 2017 | 138.32M |
| June 30, 2017 | 141.34M |
| March 31, 2017 | 139.17M |
| December 31, 2016 | 129.44M |
| September 30, 2016 | 124.18M |
| June 30, 2016 | 126.86M |
| March 31, 2016 | 118.07M |
| December 31, 2015 | 109.68M |
| September 30, 2015 | 98.05M |
| June 30, 2015 | 72.91M |
| March 31, 2015 | 46.28M |
| December 31, 2014 | 26.47M |
| September 30, 2014 | 11.56M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Anika Therapeutics, Inc. | 75.00M |
| Geron Corp. | 197.30M |
| Neurocrine Biosciences, Inc. | 3.289B |
| Aldeyra Therapeutics, Inc. | -0.2661M |
| Elicio Therapeutics, Inc. | -1.141M |